Consensus Percheron Therapeutics Limited

Equities

PER

AU0000317281

End-of-day quote Australian S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.068 ^AUD	+6.25%		-6.85%	+15.25%

Feb. 28	Percheron Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Dimerix Appoints Nonexecutive Chair	MT

Evolution of the average Target Price on Percheron Therapeutics Limited

Price target over the last 5 years

History of analyst recommendation changes

692c3e1f9284f39f4e7.UvLbiIUOnNH9mG5d8LZa9p4OtMnhB4VkGvBeDBb22dU.OMGI2NU6zYWlySIRxMY4vcY3_YyPQLMNc90HYnjC7KM2lIHbwHvtncroKw~47d07fd1109732d8979455dddd580639

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.068 AUD

Average target price

0.25 AUD

Spread / Average Target

+267.65%

High Price Target

0.27 AUD

Spread / Highest target

+297.06%

Low Price Target

0.23 AUD

Spread / Lowest Target

+238.24%

Consensus detail

Consensus revision (last 18 months)

Ratings for Percheron Therapeutics Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar